Skip to main content
. 2018 Nov 1;14:102. doi: 10.1186/s12992-018-0421-2

Fig. 3.

Fig. 3

Risk analysis and implementation workflow. Adapted with permission from A Framework for Risk-Based Resource Allocation for Pharmaceutical Quality Assurance for Medicines Regulatory Authorities in Low- and Middle-Income Countries [30]